Aspira Pathlab & Diagnostics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 06/11/2026 ,inter alia, to consider and approve Un-audited Financial Result along with Limited Review Report as on 30 September 2026.

Aspira Pathlab & Diagnostics Limited Registered. Office: Flat No. 2, R D Shah Building, Shraddhanand Road, Opp. Railway Station, Ghatkopar (W), Mumbai-400086 Corporate Office: 6 & 7, Bhaveshwar Arcade, Near Shreyas Junction LBS Marg, Behind Saraswat Bank, Ghatkopar (W), Mumbai-400086 CIN: L85100MH1973PLC289209 Date: October 31, 2026 Listing Department BSE Limited, Phiroze Jeejeebhoy Towers, Dalal Street, Mumbai-400001. Security Code: 540788 Security ID: ASPIRA Sub: Intimation of the Board Meeting to be held on November 06, 2026 for the second quarter/half year ended September 30, 2026 Ref: Regulation 29(1) of the SEBI (LODR) Regulations, 2015. Dear Sir/Madam, This is to inform you that pursuant to regulation 29(1) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Notice is hereby given that the meeting of the Board of Directors of the Company is scheduled to be held on Friday, November 06, 2026 inter alia, to consider and approve the Un-Audited Standalone Financial Results of the Company alongwith Limited Review Report for the second quarter/half year ended September 30, 2026 and to consider other businesses. Pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 and the Company’s Code of Conduct for Regulating, Monitoring and Reporting of Trading in securities by “Designated Persons Designated Persons and Immediate Relative Person”, the Trading Window for dealing in the Securities of the Company shall remain closed till 48 hours after the declaration of the Financial Results of the Company for the second Quarter and half yearly ended on the September 30, 2026. The notice of the said Board Meeting will also be uploaded on the Company’s website www.aspiradiagnostics.com as per regulation 46(2)(l)(i) of the Listing Regulations. Kindly take the same on your record. Thanking You. Yours faithfully, For Aspira Pathlab & Diagnostics Limited Nikunj Velji Mange DIN: 08489442 Managing Director INDIA’S FIRST 0227197 5756, 022 2513 9090 www.aspiradiagnostics.com FULLY INTEGRATED LAB support@aspiradiagnostics.com │info@aspiradiagnostics.com